Breaking News

You are here » Indian-Commodity  :  Commodities  :  Copper Ricochets In Spite Of Cost Rise In Leading Consumer China

13-May2011

Copper Ricochets In Spite Of Cost Rise In Leading Consumer China

Copper costs ricocheted as traders turned to discount looking after striking the minimum stages in 5 months, despite half a portion point rise in bank preserve needs for a 5th time this season by the leading buyer China. The reddish metal rates gained assistance from devaluation in American dollar that helped copper to buck demure tone arranged by other products and close store with increases of one and half a per cent.

Copper commodity for July supply increased 5.7 cents or 1.5% to stay at $3.9705 a lb on the Comex materials section of NYME . Copper for 3 month distribution on the LME enhanced by $30 or 0.3% to $8,730 a tonne.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......